BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 25367873)

  • 1. Early-onset Crohn's disease and autoimmunity associated with a variant in CTLA-4.
    Zeissig S; Petersen BS; Tomczak M; Melum E; Huc-Claustre E; Dougan SK; Laerdahl JK; Stade B; Forster M; Schreiber S; Weir D; Leichtner AM; Franke A; Blumberg RS
    Gut; 2015 Dec; 64(12):1889-97. PubMed ID: 25367873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations.
    Schubert D; Bode C; Kenefeck R; Hou TZ; Wing JB; Kennedy A; Bulashevska A; Petersen BS; Schäffer AA; Grüning BA; Unger S; Frede N; Baumann U; Witte T; Schmidt RE; Dueckers G; Niehues T; Seneviratne S; Kanariou M; Speckmann C; Ehl S; Rensing-Ehl A; Warnatz K; Rakhmanov M; Thimme R; Hasselblatt P; Emmerich F; Cathomen T; Backofen R; Fisch P; Seidl M; May A; Schmitt-Graeff A; Ikemizu S; Salzer U; Franke A; Sakaguchi S; Walker LSK; Sansom DM; Grimbacher B
    Nat Med; 2014 Dec; 20(12):1410-1416. PubMed ID: 25329329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of the Ctla-4 isoform lacking exons 2 and 3 causes autoimmunity.
    Liu SM; Sutherland AP; Zhang Z; Rainbow DB; Quintana FJ; Paterson AM; Sharpe AH; Oukka M; Wicker LS; Kuchroo VK
    J Immunol; 2012 Jan; 188(1):155-62. PubMed ID: 22124121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What did we learn from CTLA-4 insufficiency on the human immune system?
    Mitsuiki N; Schwab C; Grimbacher B
    Immunol Rev; 2019 Jan; 287(1):33-49. PubMed ID: 30565239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects.
    Schwab C; Gabrysch A; Olbrich P; Patiño V; Warnatz K; Wolff D; Hoshino A; Kobayashi M; Imai K; Takagi M; Dybedal I; Haddock JA; Sansom DM; Lucena JM; Seidl M; Schmitt-Graeff A; Reiser V; Emmerich F; Frede N; Bulashevska A; Salzer U; Schubert D; Hayakawa S; Okada S; Kanariou M; Kucuk ZY; Chapdelaine H; Petruzelkova L; Sumnik Z; Sediva A; Slatter M; Arkwright PD; Cant A; Lorenz HM; Giese T; Lougaris V; Plebani A; Price C; Sullivan KE; Moutschen M; Litzman J; Freiberger T; van de Veerdonk FL; Recher M; Albert MH; Hauck F; Seneviratne S; Pachlopnik Schmid J; Kolios A; Unglik G; Klemann C; Speckmann C; Ehl S; Leichtner A; Blumberg R; Franke A; Snapper S; Zeissig S; Cunningham-Rundles C; Giulino-Roth L; Elemento O; Dückers G; Niehues T; Fronkova E; Kanderová V; Platt CD; Chou J; Chatila TA; Geha R; McDermott E; Bunn S; Kurzai M; Schulz A; Alsina L; Casals F; Deyà-Martinez A; Hambleton S; Kanegane H; Taskén K; Neth O; Grimbacher B
    J Allergy Clin Immunol; 2018 Dec; 142(6):1932-1946. PubMed ID: 29729943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTLA-4 regulates T follicular regulatory cell differentiation and participates in intestinal damage caused by spontaneous autoimmunity.
    Chao G; Li X; Ji Y; Zhu Y; Li N; Zhang N; Feng Z; Niu M
    Biochem Biophys Res Commun; 2018 Nov; 505(3):865-871. PubMed ID: 30301533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Complexity of Crohn's Disease in Two Large Ashkenazi Jewish Families.
    Levine AP; Pontikos N; Schiff ER; Jostins L; Speed D; ; Lovat LB; Barrett JC; Grasberger H; Plagnol V; Segal AW
    Gastroenterology; 2016 Oct; 151(4):698-709. PubMed ID: 27373512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTLA-4: From mechanism to autoimmune therapy.
    Hosseini A; Gharibi T; Marofi F; Babaloo Z; Baradaran B
    Int Immunopharmacol; 2020 Mar; 80():106221. PubMed ID: 32007707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative splice forms of CTLA-4 induced by antisense mediated splice-switching influences autoimmune diabetes susceptibility in NOD mice.
    Mourich DV; Oda SK; Schnell FJ; Crumley SL; Hauck LL; Moentenich CA; Marshall NB; Hinrichs DJ; Iversen PL
    Nucleic Acid Ther; 2014 Apr; 24(2):114-26. PubMed ID: 24494586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DECTIN-1: A modifier protein in CTLA-4 haploinsufficiency.
    Turnbull C; Bones J; Stanley M; Medhavy A; Wang H; Lorenzo AMD; Cappello J; Shanmuganandam S; Pandey A; Seneviratne S; Brown GJ; Meng X; Fulcher D; Burgio G; Man SM; de Lucas Collantes C; Gasior M; López Granados E; Martin P; Jiang SH; Cook MC; Ellyard JI; Athanasopoulos V; Corry B; Canete PF; Vinuesa CG
    Sci Adv; 2023 Dec; 9(49):eadi9566. PubMed ID: 38055819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief report: increased expression of a short splice variant of CTLA-4 exacerbates lupus in MRL/lpr mice.
    Ichinose K; Zhang Z; Koga T; Juang YT; Kis-Tóth K; Sharpe AH; Kuchroo V; Crispín JC; Tsokos GC
    Arthritis Rheum; 2013 Mar; 65(3):764-9. PubMed ID: 23203389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmunity: CTLA-4: a key protein in autoimmunity.
    Bayry J
    Nat Rev Rheumatol; 2009 May; 5(5):244-5. PubMed ID: 19412189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease.
    Battaglia E; Biancone L; Resegotti A; Emanuelli G; Fronda GR; Camussi G
    Am J Gastroenterol; 1999 Nov; 94(11):3279-84. PubMed ID: 10566730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTLA4 gene variants in autoimmunity and cancer: a comparative review.
    Ghaderi A
    Iran J Immunol; 2011 Sep; 8(3):127-49. PubMed ID: 21931200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression and secretion of the soluble CTLA-4 splice variant in various autoimmune diseases and in cases with overlapping autoimmunity.
    AlFadhli S
    Genet Test Mol Biomarkers; 2013 Apr; 17(4):336-41. PubMed ID: 23448385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of Cytotoxic T-Lymphocyte-Associated Antigen-4 Prevents Atherosclerosis in Mice.
    Matsumoto T; Sasaki N; Yamashita T; Emoto T; Kasahara K; Mizoguchi T; Hayashi T; Yodoi K; Kitano N; Saito T; Yamaguchi T; Hirata K
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1141-51. PubMed ID: 27055906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Patient with CTLA-4 Haploinsufficiency with Multiple Autoimmune Presentations: A Case Report.
    Zaremehrjardi F; Baniadam L; Seif F; Arshi S; Bemanian MH; Shokri S; Rezaeifar A; Fallahpour M; Nabavi M
    Iran J Immunol; 2020 Sep; 17(3):244-249. PubMed ID: 32996901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposing effects of CTLA4 insufficiency on regulatory versus conventional T cells in autoimmunity converge on effector memory in target tissue.
    Devarajan P; Miska J; Lui JB; Swieboda D; Chen Z
    J Immunol; 2014 Nov; 193(9):4368-80. PubMed ID: 25246499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exome sequencing identifies DLG1 as a novel gene for potential susceptibility to Crohn's disease in a Chinese family study.
    Xu S; Zhou F; Tao J; Song L; Ng SC; Wang X; Chen L; Yi F; Ran Z; Zhou R; Xia B
    PLoS One; 2014; 9(6):e99807. PubMed ID: 24937328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Expression of Cytotoxic T-Lymphocyte-Associated Protein 4 by T Cells, Induced by B7 in Sera, Reduces Adaptive Immunity in Patients With Acute Liver Failure.
    Khamri W; Abeles RD; Hou TZ; Anderson AE; El-Masry A; Triantafyllou E; Bernsmeier C; Larsen FS; Singanayagam A; Kudo N; Possamai LA; Lebosse F; Auzinger G; Bernal W; Willars C; Weston CJ; Lombardi G; Wendon J; Thursz M; Antoniades CG
    Gastroenterology; 2017 Jul; 153(1):263-276.e8. PubMed ID: 28363639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.